Trademark: XIIDRA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for XIIDRA
We do not have any records of a proof of use for XIIDRA at this moment.
Possible trademark infringements of XIIDRA
Basic Information about XIIDRA
- Serial Number
- 86056637
- Filing Date
- 05 Sep 2013
- Registration Number
- 5050074
- Registration Date
- 27 Sep 2016
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of XIIDRA on the blockchain with WikiTrademarks.io.
- First use of XIIDRA anywhere
- XIIDRA was first used on 18 Jul 2016 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns XIIDRA?
1. BAUSCH + LOMB IRELAND LIMITED DUBLIN
2. NOVARTIS AG BASEL
3. SARcode Bioscience Inc. Lexington MA
4. SARcode Bioscience Inc. Brisbane CA
5. SARcode Bioscience Inc. Brisbane CA
Correspondent
- Nancy L. Rowe
- Bausch + Lomb
- 400 Somerset Corp. Blvd.
- Bridgewater,NJ 08807
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io